BR0110954A - Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori - Google Patents

Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori

Info

Publication number
BR0110954A
BR0110954A BR0110954-5A BR0110954A BR0110954A BR 0110954 A BR0110954 A BR 0110954A BR 0110954 A BR0110954 A BR 0110954A BR 0110954 A BR0110954 A BR 0110954A
Authority
BR
Brazil
Prior art keywords
pylori infection
pharmaceutical preparation
helicobacter pylori
preparation
infection
Prior art date
Application number
BR0110954-5A
Other languages
English (en)
Inventor
Kyoko Tsuchiya
Akio Okamura
Junichi Kawasaki
Shinichiro Uno
Atsunari Noda
Satoshi Nishiwaki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26592228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0110954(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BR0110954A publication Critical patent/BR0110954A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Atmospheric Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PREPARAçãO FARMACêUTICA PARA DIAGNóSTICO DE INFECçãO POR HELICOBACTER PYLORI". A presente invenção refere-se a uma preparação revestida para a detecção de uma infecção por H. pylori de acordo com um protocolo de teste de sopro de uréia que compreende uma composição de núcleo contendo pelo menos uma uréia rotulada com isótopo de C, um excipiente e um lubrificante em proporções definidas e revestida com 0,1-10 partes em peso de um agente de revestimento com base em 100 partes em peso da composição de núcleo. Com esta preparação, a influência das bactérias produtoras de urease residentes em órgãos que não o estómago, tais como a boca e a garganta, é excluída para permitir um diagnóstico de infecção por H. pylori sem o risco de um teste falso-positivo e com rapidez razoável.
BR0110954-5A 2000-05-19 2001-05-17 Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori BR0110954A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000148150 2000-05-19
JP2000259845 2000-08-29
PCT/JP2001/004122 WO2001087353A1 (en) 2000-05-19 2001-05-17 Preparations for diagnosing infection with helicobacter pylori

Publications (1)

Publication Number Publication Date
BR0110954A true BR0110954A (pt) 2005-01-11

Family

ID=26592228

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110954-5A BR0110954A (pt) 2000-05-19 2001-05-17 Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori

Country Status (13)

Country Link
EP (1) EP1283060B1 (pt)
JP (1) JP4683812B2 (pt)
KR (1) KR100774014B1 (pt)
CN (1) CN1263516C (pt)
AU (2) AU2001256768B2 (pt)
BR (1) BR0110954A (pt)
CA (1) CA2408992C (pt)
DE (1) DE60143196D1 (pt)
HK (1) HK1063741A1 (pt)
MX (1) MXPA02011424A (pt)
PT (1) PT1283060E (pt)
TW (1) TWI296530B (pt)
WO (1) WO2001087353A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2432642A1 (en) 2000-12-21 2002-08-08 Subhash P. Khanapure Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
US20080146956A1 (en) * 2006-12-17 2008-06-19 Campuzano German A Method based on a breath test for the detection of pathogen microorganisms
CN101231284B (zh) * 2007-01-23 2012-09-26 深圳市先亚生物科技有限公司 诊断幽门螺杆菌感染的尿素试剂盒
ITMI20121462A1 (it) * 2012-08-31 2014-03-01 Francesco Maria Bulletti Preparato a rilascio vaginale per la diagnosi della pervietà e della funzione utero tubarica femminile umana finalizzata alla fecondazione dei gameti
CN106620736A (zh) * 2016-11-09 2017-05-10 北京勃然制药有限公司 一种新型尿素[13c]检测药剂
KR102637908B1 (ko) 2018-12-28 2024-02-20 씨제이제일제당 (주) 헬리코박터 파일로리 연관 질환에 대한 유전자 마커

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06157317A (ja) * 1992-11-19 1994-06-03 Nisshin Flour Milling Co Ltd 消化性潰瘍治療剤
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
JP2768559B2 (ja) * 1994-11-02 1998-06-25 ダイアバクト・エイ・ビー ヘリコバクテル・ピロリ（Ｈｅｌｉｃｏｂａｃｔｅｒ Ｐｙｌｏｒｉ）の検出のための診断用調剤
TW438608B (en) * 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin
JP3963982B2 (ja) * 1995-08-02 2007-08-22 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
CN1087178C (zh) * 1996-08-13 2002-07-10 协和发酵工业株式会社 同位素标记的尿素片
AU6050298A (en) * 1997-01-31 1998-08-25 Elisha Technologies Co. L.L.C. Corrosion protective coatings
MX9703918A (es) * 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.

Also Published As

Publication number Publication date
JPWO2001087353A1 (ja) 2004-04-30
CN1489478A (zh) 2004-04-14
CA2408992A1 (en) 2002-11-18
EP1283060A1 (en) 2003-02-12
AU2001256768B2 (en) 2006-03-02
CN1263516C (zh) 2006-07-12
MXPA02011424A (es) 2003-04-25
DE60143196D1 (de) 2010-11-18
KR20030001506A (ko) 2003-01-06
EP1283060B1 (en) 2010-10-06
TWI296530B (en) 2008-05-11
JP4683812B2 (ja) 2011-05-18
AU5676801A (en) 2001-11-26
CA2408992C (en) 2010-03-23
PT1283060E (pt) 2010-11-22
KR100774014B1 (ko) 2007-11-08
WO2001087353A1 (en) 2001-11-22
HK1063741A1 (en) 2005-01-14
EP1283060A4 (en) 2006-03-22

Similar Documents

Publication Publication Date Title
Tabak et al. Role of salivary mucins in the protection of the oral cavity
Snyders et al. Oral chlorhexidine in the prevention of ventilator-associated pneumonia in critically ill adults in the ICU: a systematic review
Asikainen et al. Certain bacterial species and morphotypes in localized juvenile periodontitis and in matched controls
Bayindir et al. Nitric oxide concentrations in saliva and dental plaque in relation to caries experience and oral hygiene
BR0110954A (pt) Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori
DE69531613D1 (de) Einführung einer thiol-gruppe in proteine für die radioimmundetektion und radioimmuntherapie auf der basis von radionukliden
BR112021024274A2 (pt) Composições para tratamento bucal sem enxágue
Bergogue-Bèrézin Predicting the efficacy of antimicrobial agents in respiratory infections—is tissue concentration a valid measure?
Saghiri et al. Subcutaneous connective tissue reactions to various endodontic biomaterials: an animal study
SE8903625D0 (sv) Antibacterial composition
BR9813856A (pt) Processos para o tratamento de uma paciente que sofre de sìndrome pré-menstrual, depressão, anemia, enxaquecas ou distúrbios alimentares e para aumentar o nìvel de serotonin em um ser humano com nìvel reduzido do mesmo no fluxo sanguìneo e composição
Dunn et al. Ammonia vapour in the mouth as a diagnostic marker for Helicobacter pylori infection: preliminary'proof of principle'pharmacological investigations
DE69713588D1 (de) Diagnostische zusammensetzung
Crouse et al. A longitudinal study of nasal airway size from age 9 to age 13
BR9914945A (pt) Processo para proporcionar terapiacosmética/medicinal
BR9811422A (pt) Processo para a inibição de hiperplasia celular de músculo liso vascular em um paciente humano ou em outro paciente animal de sangue quente necessitando de tal tratamento, uso de pelo menos um oligossacarìdeo sulfatado, e, composição farmacêutica ou veterinária para a inibição de hiperplasia celular de músculo liso vascular
Roberge et al. Glossal abscess
Moreno et al. Tratamento da periodontite agressiva e alterações nos compostos sulfurados voláteis
Zahid et al. THE INFLUENCE OF MOISTURE ON THE SETTING TIME OF THE LATEST COMMERCIALLY AVAILABLE CALCIUM HYDROXIDE CEMENTS; A CLEAR GUIDELINE FOR THE DENTIST.
Yaegaki et al. The effect of mouthwash on oral malodour production
Davidovic-Plavsic et al. Urinary activities of proximal tubule enzymes in neonates treated with gentamicin
Sari et al. Evaluation of the applicability of temporomandibular opening index in Turkish children with and without signs and symptoms of temporomandibular joint disorders
Mustafoevich INFLAMMATORY DISEASES OF MAXILLOFACIAL DISEASES COMPLICATIONS.
Schlesinger et al. Pulmonary effects of repeated episodic exposures to nitric acid vapor alone and in combination with ozone
ORA 1330 DEC. 12, 1953 MEDICO-LEGAL RMEDICALJouRT

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 51/04, 9/30, 47/02, 47/10, 47/14, 47/26, 47/32, 47/36, 47/38; A61P 31/00

Ipc: A61K 51/04 (2011.01), A61K 9/30 (2011.01), A61K 47

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time